Bovine virus vaccines that are liquid stable
AssigneeIntervet Inc.
InventorsBrad Eddy, Zhisong Qiao, Kevin O'Connell
Life of this patent
Estimating the term…
Abstract
The present invention discloses liquid stable bovine vaccines that comprise a live attenuated virus, and a sugar alcohol. The present invention also discloses the manufacture of such vaccines and methods of protecting an animal by administration of such vaccines.
Claims20
A liquid stable vaccine that comprises a live attenuated bovine respiratory coronavirus (BRCV), a 5-40% (w/v) sugar alcohol, and 0.15 to 0.75 M of an amino acid selected from the group consisting of arginine, glutamic acid, glycine, and any combination thereof;
- wherein the liquid stable vaccine has a pH of 6.0 to 8.0.
A method of making a liquid stable vaccine that comprises combining a therapeutically effective amount of a live attenuated bovine respiratory coronavirus (BRCV) with a 5-40% (w/v) sugar alcohol, and 0.15 to 0.75 M arginine;
- wherein the liquid stable vaccine has a pH of 6.0 to 8.0.
Dependencies are inferred from the claim text.